D-0671-2026 Class II Ongoing
FDA drug recall D-0671-2026 was initiated by Reliance Life Sciences Private Limited on June 24, 2026 and is designated Class II. Reason for recall: Lack of Sterility Assurance The recall status is ongoing. Affected quantity: 12,000 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- July 15, 2026
- Initiation Date
- June 24, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,000 vials
Product Description
Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
Reason for Recall
Lack of Sterility Assurance
Distribution Pattern
Nationwide in the USA
Code Information
Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028